2 August 2023
Duke Royalty Limited
("Duke Royalty" or "Duke")
Result of Annual General Meeting
Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.
Detailed voting results will be made available to view on the Company's website shortly.
***ENDS***
For further information, please visit www.dukeroyalty.com or contact:
Duke Royalty Limited |
Neil Johnson / Charles Cannon Brookes / Hugo Evans |
+44 (0) 1481 231 816 |
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) |
Stephen Keys / Callum Davidson / Michael Johnson |
+44 (0) 207 397 8900 |
|
Canaccord Genuity (Joint Broker) |
Adam James / Harry Rees |
+44 (0) 207 523 8000 |
SEC Newgate (PR) |
Elisabeth Cowell / Alice Cho / Matthew Elliott |
+ +44 (0) 20 3757 [email protected] |
About Duke Royalty
Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDRAGNKBBPPBKDKFK
==